Annie Dori
Senior Partnership Manager
Working groups
Background
Annie holds a Bachelor of Science in Nursing (BSN) and has worked alongside the National Malaria and Vector Borne Disease program in Papua New Guinea for 7 years. Throughout this time, she has played a pivotal role in advancing public health efforts, specifically focusing on malaria and other vector-borne diseases.
Currently, Annie provides strategic partnership support to various malaria and vector-borne disease research projects in several provinces in Papua New Guinea. She has expanded the partnership approach in PNG to neighbouring countries in the Pacific, such as Solomon Islands and Vanuatu, where she works to strengthen regional health initiatives and collaborate with local partners.
Qualifications
- 2014: Bachelor of Science in Nursing, Pacific Adventist University, Papua New Guinea
Positions
- 2023–present: Partnership Manager, Vector Borne Diseases and Tropical Public Health Group, Burnet Institute
- 2019–2023: Project Partnership Coordinator, Australia-China Papua New Guinea Cooperation on Malaria and Health Systems, ABT Associates
- 2018–2019: Intern, Australia-China Papua New Guinea Cooperation on Malaria and Health Systems, ABT Associates
- 2015–2017: Graduate Nurse, Ok Tedi Mine Limited
Burnet publications
Baseline assessment of front-line health system capacity in vector-borne disease surveillance and response in Papua New Guinea
PLOS Global Public Health
Rachael Farquhar et al
Protecting global health partnerships in the era of destructive nationalism
PLOS Global Public Health
Maya Adam et al
Current projects
View 1 more
STRIVE: stronger surveillance for vector-borne pathogens
Infectious diseases are an increasing global health threat, especially in low- and middle-income countries.
ADVANCE: improving access to malaria diagnosis tools in the Indo-Pacific
We work to increase access to new diagnostic tools for malaria, reduce health inequities and accelerate malaria elimination.
PAVE PNG: partnership for vivax elimination
Despite reducing the overall burden of malaria in Papua New Guinea, the prevalence of P. vivax remains unacceptably high and is a key barrier in elimination.